Nebenwirkungen · MabThera
MabThera 100 mg concentrate for solution for infusion MabThera 500 mg concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 17
HOS-087544 · Präparat HOS-083527
Vascular hypertension, vasculitis disorders orthostatic (predominately hypotension, cutaneous), hypotension leukocytoclastic vasculitis Respiratory, bronchospasm5, asthma, interstitial lung respiratory lung infiltration thoracic and respiratory bronchiolitis disease8 failure5 mediastinal disease, obliterans, disorders chest pain, lung disorder, dyspnoea, hypoxia increased cough, rhinitis Gastrointestinal nausea vomiting, abdominal gastro-intestinal disorders diarrhoea, enlargement perforation8 abdominal pain, dysphagia, stomatitis, constipation, dyspepsia, anorexia, throat irritation Skin and pruritus, urticaria, severe bullous subcutaneous rash, sweating, skin reactions, tissue disorders +alopecia night sweats, Stevens-Johnson +skin disorder syndrome, toxic epidermal necrolysis (Lyell’s syndrome)8 Musculoskeletal hypertonia, and connective myalgia, tissue disorders arthralgia, back pain, neck pain, pain Renal and renal failure5 urinary disorders
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-06T15:15:00Z · SHA-256 595c4e1a263e9a34be8b62842a5fc67f95f6a1b1f2a250341444a2960c6c3962 · Passage cf3f6c972f6989cebb7c8218d1915f0f0d05ea21e2a34fbcc112afccdf4b4c63 · Zeichen 7285–10232 im Abschnitt